discovery of novel therapeutics – activity modulators of clinically relevant Cytochromes P450
(the research is carried out with grant support from Skolkovo Foundation)
Aldosterone synthase inhibitor is a highly anticipated drug for cardio-metabolic indications. The drug will selectively inhibit synthesis of hormone aldosterone to manage deleterious effects of its excess.